Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for delirium prevention in ICU patients
IRCT20250913067232N1Phase 3Completed
- Sponsor
- Golestan University of Medical Sciences
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in delirium comparing Melatonin with Placebo (2 arms). Primary endpoints: Delirium incidence, ICU length of stay and 2 more. Started Dec 2025; status: completed.
02
Drugs
melatonin
03
Conditions
delirium
Beyond the preview
Go deeper on IRCT20250913067232N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250913067232N1.